» Articles » PMID: 30867863

Impact of Poloxamer 188 (Pluronic F-68) Additive on Cell Mechanical Properties, Quantification by Real-time Deformability Cytometry

Overview
Date 2019 Mar 15
PMID 30867863
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in cellular therapies have led to the development of new approaches for cell product purification and formulation, e.g., utilizing cell endogenous properties such as size and deformability as a basis for separation from potentially harmful undesirable by-products. However, commonly used additives such as Pluronic F-68 and other poloxamer macromolecules can change the mechanical properties of cells and consequently alter their processing. In this paper, we quantified the short-term effect of Pluronic F-68 on the mechanotype of three different cell types (Jurkat cells, red blood cells, and human embryonic kidney cells) using real-time deformability cytometry. The impact of the additive concentration was assessed in terms of cell size and deformability. We observed that cells respond progressively to the presence of Pluronic F-68 within first 3 h of incubation and become significantly stiffer (p-value < 0.001) in comparison to a serum-free control and a control containing serum. We also observed that the short-term response manifested as cell stiffening is true (p-value < 0.001) for the concentration reaching 1% (w/v) of the poloxamer additive in tested buffers. Additionally, using flow cytometry, we assessed that changes in cell deformability triggered by addition of Pluronic F-68 are not accompanied by size or viability alterations.

Citing Articles

Perfusion Process Intensification for Lentivirus Production Using a Novel Scale-Down Model.

Klimpel M, Pfluger-Muller B, Cascallana M, Schwingal S, Lal N, Noll T Biotechnol Bioeng. 2024; 122(2):344-360.

PMID: 39535315 PMC: 11718438. DOI: 10.1002/bit.28880.


Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies.

Atrooz O, Reihani N, Mozafari M, Salawi A, Taghavi E ADMET DMPK. 2024; 12(3):431-462.

PMID: 39091900 PMC: 11289513. DOI: 10.5599/admet.2376.


Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.

Uner B, Ozdemir S, Tas C, Uner M, Ozsoy Y AAPS PharmSciTech. 2023; 24(4):92.

PMID: 36977841 DOI: 10.1208/s12249-023-02551-6.


Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors.

Gallego-Murillo J, Iacono G, van der Wielen L, van den Akker E, von Lindern M, Wahl S Biotechnol Bioeng. 2022; 119(11):3096-3116.

PMID: 35879812 PMC: 9804173. DOI: 10.1002/bit.28193.


The Effect of Glucose and Poloxamer 188 on Red-Blood-Cell Aggregation.

Szolna-Chodor A, Grzegorzewski B Metabolites. 2021; 11(12).

PMID: 34940644 PMC: 8706508. DOI: 10.3390/metabo11120886.


References
1.
Smith 2nd C, Hebbel R, Tukey D, Clawson C, White J, Vercellotti G . Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. Blood. 1987; 69(6):1631-6. View

2.
Toepfner N, Herold C, Otto O, Rosendahl P, Jacobi A, Krater M . Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood. Elife. 2018; 7. PMC: 5790376. DOI: 10.7554/eLife.29213. View

3.
Wang N, Butler J, Ingber D . Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993; 260(5111):1124-7. DOI: 10.1126/science.7684161. View

4.
Tsai M, Waugh R, Keng P . Cell cycle-dependence of HL-60 cell deformability. Biophys J. 1996; 70(4):2023-9. PMC: 1225171. DOI: 10.1016/S0006-3495(96)79768-0. View

5.
Karleta V, Andrlik I, Braunmuller S, Franke T, Wirth M, Gabor F . Poloxamer 188 supplemented culture medium increases the vitality of Caco-2 cells after subcultivation and freeze/thaw cycles. ALTEX. 2010; 27(3):191-7. View